Teladoc Health
TDOC
Teladoc Health (TDOC) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.21
- EPS estimate
- −$0.25
- EPS surprise
- +15.90%
- Revenue surprise
- −1.38%
- Revenue
- $606.9M
- Revenue estimate
- $615.4M
- Reported
- Jul 29, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 29, 2026 | −$0.25 | −$0.21 | +15.90% | $606.9M | SEC |
| Q1 2026 | Apr 29, 2026 | −$0.34 | −$0.36 | −5.51% | $613.8M | SEC |
| Q4 2025 | Feb 25, 2026 | −$0.18 | −$0.14 | +21.92% | $642.3M | SEC |
| Q3 2025 | Oct 29, 2025 | −$0.26 | −$0.28 | −6.22% | $626.4M | SEC |
| Q2 2025 | Jul 29, 2025 | −$0.26 | −$0.19 | +26.33% | $631.9M | SEC |
| Q1 2025 | Apr 30, 2025 | −$0.34 | −$0.53 | −56.53% | $629.4M | SEC |
| Q4 2024 | Feb 26, 2025 | −$0.26 | −$0.28 | −7.03% | $640.5M | SEC |
| Q3 2024 | Oct 30, 2024 | −$0.28 | −$0.19 | +31.41% | $640.5M | SEC |
| Q2 2024 | Jul 31, 2024 | −$0.34 | −$4.92 | −1327.74% | $642.4M | SEC |
| Q1 2024 | Apr 25, 2024 | −$0.46 | −$0.49 | −6.85% | $646.1M | SEC |
| Q4 2023 | Feb 20, 2024 | −$0.22 | −$0.17 | +22.48% | $660.5M | SEC |
| Q3 2023 | Oct 24, 2023 | −$0.36 | −$0.35 | +3.98% | $660.2M | SEC |
| Q2 2023 | Jul 25, 2023 | −$0.41 | −$0.40 | +1.60% | $652.4M | SEC |
| Q1 2023 | Apr 26, 2023 | −$0.48 | −$0.42 | +13.24% | $629.2M | SEC |
| Q4 2022 | Feb 22, 2023 | −$0.25 | −$23.49 | −9452.66% | $637.7M | SEC |
| Q3 2022 | Oct 26, 2022 | −$0.57 | −$0.45 | +20.41% | $611.4M | SEC |
| Q2 2022 | Jul 27, 2022 | −$0.61 | −$19.22 | −3045.66% | $592.4M | SEC |
| Q1 2022 | Apr 27, 2022 | −$0.60 | −$41.58 | −6843.89% | $565.4M | SEC |
| Q4 2021 | Feb 22, 2022 | −$0.57 | −$0.07 | +87.68% | $554.2M | SEC |
| Q3 2021 | Oct 27, 2021 | −$0.67 | −$0.53 | +21.12% | $521.7M | SEC |
Quarterly revenue
Frequently asked questions
When did Teladoc Health (TDOC) last report earnings?
Teladoc Health last reported on Jul 29, 2026, covering fiscal Q2 2026.
Did TDOC beat earnings estimates?
Yes. Teladoc Health reported EPS of −$0.21 for Q2 2026 against a −$0.25 estimate — a 15.90% beat.
How much revenue did TDOC report last quarter?
Teladoc Health reported $606.9M in revenue for Q2 2026, against a consensus estimate of $615.4M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.